Overview
Autosomal dominant hereditary axonal motor and sensory neuropathy is a subtype of Charcot-Marie-Tooth disease type 2 (CMT2), a group of inherited peripheral neuropathies characterized by progressive degeneration of peripheral nerve axons rather than the myelin sheath. This condition primarily affects the peripheral nervous system, leading to progressive weakness and atrophy of distal muscles, particularly in the feet, lower legs, and hands. Sensory loss in a stocking-glove distribution is also a hallmark feature, and patients may experience reduced or absent deep tendon reflexes, foot deformities (such as pes cavus and hammer toes), and difficulties with balance and gait. The disease follows an autosomal dominant inheritance pattern, meaning that a single copy of the pathogenic variant inherited from one affected parent is sufficient to cause the condition. Multiple genetic loci have been associated with autosomal dominant CMT2, including mutations in genes such as MFN2, MPZ, NEFL, HSPB1, and others. Nerve conduction studies typically show normal or near-normal conduction velocities (above 38 m/s in the motor nerves of the upper limbs), distinguishing axonal forms from demyelinating forms of CMT. Onset is variable but often occurs in childhood, adolescence, or early adulthood, with a slowly progressive course. There is currently no cure or disease-modifying therapy for autosomal dominant hereditary axonal motor and sensory neuropathy. Management is supportive and multidisciplinary, including physical therapy to maintain muscle strength and flexibility, occupational therapy, orthotic devices (such as ankle-foot orthoses) to improve mobility, and surgical intervention for severe skeletal deformities when necessary. Pain management may be required for patients who experience neuropathic pain. Genetic counseling is recommended for affected individuals and their families.
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Autosomal dominant hereditary axonal motor and sensory neuropathy.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Autosomal dominant hereditary axonal motor and sensory neuropathy at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Autosomal dominant hereditary axonal motor and sensory neuropathy.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Autosomal dominant hereditary axonal motor and sensory neuropathy.
Community
No community posts yet. Be the first to share your experience with Autosomal dominant hereditary axonal motor and sensory neuropathy.
Start the conversation →Latest news about Autosomal dominant hereditary axonal motor and sensory neuropathy
No recent news articles for Autosomal dominant hereditary axonal motor and sensory neuropathy.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Autosomal dominant hereditary axonal motor and sensory neuropathy
What is Autosomal dominant hereditary axonal motor and sensory neuropathy?
Autosomal dominant hereditary axonal motor and sensory neuropathy is a subtype of Charcot-Marie-Tooth disease type 2 (CMT2), a group of inherited peripheral neuropathies characterized by progressive degeneration of peripheral nerve axons rather than the myelin sheath. This condition primarily affects the peripheral nervous system, leading to progressive weakness and atrophy of distal muscles, particularly in the feet, lower legs, and hands. Sensory loss in a stocking-glove distribution is also a hallmark feature, and patients may experience reduced or absent deep tendon reflexes, foot deformit
How is Autosomal dominant hereditary axonal motor and sensory neuropathy inherited?
Autosomal dominant hereditary axonal motor and sensory neuropathy follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.